Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Research
100%
Therapeutic Development
100%
Related Disorders
100%
Amyotrophic Lateral Sclerosis
100%
Rare Diseases
50%
Research Consortium
16%
Clinical Trials
16%
Electronic Health Records
16%
Clinical Trials Network
16%
Multidisciplinary Groups
16%
Physician-scientist
16%
Etiological Heterogeneity
16%
Community Stakeholders
16%
Biological Heterogeneity
16%
Therapy Development
16%
Multisystem Proteinopathy
16%
Hereditary Spastic Paraplegia
16%
Patient Advocacy Groups
16%
Amyotrophic Lateral Sclerosis/frontotemporal Dementia
16%
Patient Participation
16%
Biorepository
16%
Phenotypic Heterogeneity
16%
Fit-for-purpose
16%
Progressive muscular Atrophy
16%
Paucity
16%
Collaborative Research
16%
Participation in Research
16%
Clinical Outcome Measures
16%
National Institutes of Health
16%
Scientific Community
16%
Strategic Partner
16%
Translational Scientist
16%
Educators
16%
Medicine and Dentistry
Clinical Research
100%
Amyotrophic Lateral Sclerosis
100%
Rare Disease
50%
Patient Participation
16%
Frontotemporal Lobar Degeneration
16%
Electronic Health Record
16%
Educators
16%
Biological Marker
16%
Biorepository
16%
Patient Advocacy
16%
DeJerine-Sottas Disease
16%
Progressive Muscular Atrophy
16%
Primary Lateral Sclerosis
16%
Therapy Development
16%
Clinician
16%
Nursing and Health Professions
Amyotrophic Lateral Sclerosis
100%
Rare Disease
50%
Collaborative Research
16%
Primary Lateral Sclerosis
16%
Progressive Muscular Atrophy
16%
Biological Marker
16%
Clinical Outcome
16%
Hereditary Motor Sensory Neuropathy
16%
Biobank
16%
National Health Organization
16%
Electronic Health Record
16%
Frontotemporal Dementia
16%
Patient Participation
16%